{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:03:20Z","timestamp":1791198200784,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81100369"],"award-info":[{"award-number":["81100369"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Planning Project of Guangzhou City","award":["11C22130682"],"award-info":[{"award-number":["11C22130682"]}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"crossref","award":["2013B021800084"],"award-info":[{"award-number":["2013B021800084"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["S2012040007921"],"award-info":[{"award-number":["S2012040007921"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2014A030313580"],"award-info":[{"award-number":["2014A030313580"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010883","name":"Administration of Traditional Chinese Medicine of Guangdong Province","doi-asserted-by":"crossref","award":["20121156"],"award-info":[{"award-number":["20121156"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.leukres.2015.07.008","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T19:59:59Z","timestamp":1437508799000},"page":"1117-1124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Silencing of miR-21 sensitizes CML CD34+ stem\/progenitor cells to imatinib-induced apoptosis by blocking PI3K\/AKT pathway"],"prefix":"10.1016","volume":"39","author":[{"given":"Wei-Zhang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Hong","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Rong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Qing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Heng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen-Fang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2015.07.008_bib0005","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.07.008_bib0010","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nature03669","article-title":"Dynamics of chronic myeloid leukaemia","volume":"435","author":"Michor","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2015.07.008_bib0015","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nm1487","article-title":"Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications","volume":"12","author":"Roeder","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.leukres.2015.07.008_bib0020","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1182\/blood.V99.10.3792","article-title":"Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation","volume":"99","author":"Holtz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.07.008_bib0025","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.leukres.2015.07.008_bib0030","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.leukres.2015.07.008_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2015.07.008_bib0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.canlet.2009.04.031","article-title":"MicroRNAs novel regulators in the hallmarks of human cancer","volume":"285","author":"Ruan","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.leukres.2015.07.008_bib0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1101\/gr.098046.109","article-title":"Reprogramming of miRNA networks in cancer and leukemia","volume":"20","author":"Volinia","year":"2010","journal-title":"Genome Res."},{"key":"10.1016\/j.leukres.2015.07.008_bib0050","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4161\/cbt.10.12.14252","article-title":"MicroRNA-21: a novel therapeutic target in human cancer","volume":"10","author":"Pan","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.leukres.2015.07.008_bib0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature09284","article-title":"OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma","volume":"467","author":"Medina","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2015.07.008_bib0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drup.2010.02.001","article-title":"Implication of microRNAs in drug resistance for designing novel cancer therapy","volume":"13","author":"Sarkar","year":"2010","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.leukres.2015.07.008_bib0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3727\/096504010X12828372551759","article-title":"AP-1-Dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells","volume":"19","author":"Misawa","year":"2010","journal-title":"Oncol. Res."},{"key":"10.1016\/j.leukres.2015.07.008_bib0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/scrt247","article-title":"MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem\/progenitor populations in vitro","volume":"4","author":"Chung","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.leukres.2015.07.008_bib0075","doi-asserted-by":"crossref","first-page":"e39520","DOI":"10.1371\/journal.pone.0039520","article-title":"Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT\/ERK1\/2 inactivation by targeting PTEN","volume":"7","author":"Han","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2015.07.008_bib0080","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1349-7006.2012.02281.x","article-title":"MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1alpha expression in third-sphere forming breast cancer stem cell-like cells","volume":"103","author":"Han","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2015.07.008_bib0085","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1349-7006.2010.01489.x","article-title":"Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis","volume":"101","author":"Li","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2015.07.008_bib0090","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.febslet.2010.12.027","article-title":"Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line","volume":"585","author":"Bai","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.leukres.2015.07.008_bib0095","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2014.10.107","article-title":"Targeting miR-21 sensitizes Ph+ ALL Sup-b15 cells to imatinib-induced apoptosis through upregulation of PTEN","volume":"454","author":"Wang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.leukres.2015.07.008_bib0100","doi-asserted-by":"crossref","first-page":"8108","DOI":"10.1158\/0008-5472.CAN-10-2579","article-title":"IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2015.07.008_bib0105","doi-asserted-by":"crossref","first-page":"e47449","DOI":"10.1371\/journal.pone.0047449","article-title":"Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K\/AKT pathway and enhancing autophagy in malignant glioma cell lines","volume":"7","author":"Gwak","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2015.07.008_bib0110","doi-asserted-by":"crossref","first-page":"617868","DOI":"10.1155\/2014\/617868","article-title":"Silencing miR-21 sensitizes non-small cell lung cancer A549 cells to ionizing radiation through inhibition of PI3K\/Akt","volume":"2014","author":"Ma","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.leukres.2015.07.008_bib0115","doi-asserted-by":"crossref","first-page":"e19946","DOI":"10.1371\/journal.pone.0019946","article-title":"Sphingosine kinase 1 regulates the Akt\/FOXO3a\/Bim pathway and contributes to apoptosis resistance in glioma cells","volume":"6","author":"Guan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2015.07.008_bib0120","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2015.07.008_bib0125","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.4049\/jimmunol.172.9.5522","article-title":"Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levels","volume":"172","author":"Chandramohan","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.leukres.2015.07.008_bib0130","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1084\/jem.20110304","article-title":"BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia","volume":"208","author":"Hurtz","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.leukres.2015.07.008_bib0135","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.cell.2013.05.041","article-title":"The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability","volume":"153","author":"King","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2015.07.008_bib0140","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1-positive chronic myeloid leukemia","volume":"113","author":"Quintas-Cardama","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.07.008_bib0145","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1056\/NEJMoa0912614","article-title":"Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia","volume":"362","author":"Saglio","year":"2010","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.leukres.2015.07.008_bib0150","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1056\/NEJMoa1002315","article-title":"Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia","volume":"362","author":"Kantarjian","year":"2010","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.leukres.2015.07.008_bib0155","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","article-title":"Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment","volume":"118","author":"Chu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.07.008_bib0160","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","article-title":"Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib","volume":"21","author":"Li","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2015.07.008_bib0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccr.2013.01.026","article-title":"Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence","volume":"23","author":"Takeishi","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2015.07.008_bib0170","doi-asserted-by":"crossref","first-page":"12740","DOI":"10.1073\/pnas.1109987108","article-title":"MicroRNA-21 regulates the self-renewal of mouse spermatogonial stem cells","volume":"108","author":"Niu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2015.07.008_bib0175","doi-asserted-by":"crossref","first-page":"e59397","DOI":"10.1371\/journal.pone.0059397","article-title":"Targeted ablation of miR-21 decreases murine eosinophil progenitor cell growth","volume":"8","author":"Lu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2015.07.008_bib0180","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1182\/blood-2011-07-366203","article-title":"The PI3K\/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia","volume":"119","author":"Polak","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.07.008_bib0185","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1038\/cddis.2013.309","article-title":"PI3K\/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor","volume":"4","author":"Airiau","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.leukres.2015.07.008_bib0190","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-07-037572","article-title":"Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis","volume":"111","author":"Buitenhuis","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.07.008_bib0195","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0278-6915(89)90066-5","article-title":"Acute pathological effects on rats of orally administered wortmannin-containing preparations and purified wortmannin from Fusarium oxysporum","volume":"27","author":"Gunther","year":"1989","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.leukres.2015.07.008_bib0200","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1158\/0008-5472.CAN-05-1278","article-title":"Simultaneous inhibition of PDK1\/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP 372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia","volume":"66","author":"Zeng","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2015.07.008_bib0205","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.leukres.2015.07.008_bib0210","doi-asserted-by":"crossref","first-page":"8157","DOI":"10.1158\/0008-5472.CAN-09-1996","article-title":"microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2015.07.008_bib0215","doi-asserted-by":"crossref","first-page":"26533","DOI":"10.1074\/jbc.M109.027466","volume":"284","author":"Bourguignon","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2015.07.008_bib0220","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1158\/1541-7786.MCR-09-0465","article-title":"Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB","volume":"8","author":"Connolly","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.leukres.2015.07.008_bib0225","doi-asserted-by":"crossref","first-page":"21098","DOI":"10.1073\/pnas.1015541107","article-title":"MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)","volume":"107","author":"Valeri","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2015.07.008_bib0230","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1038\/cddis.2013.3","article-title":"PTEN-regulated AKT\/FoxO3a\/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells","volume":"4","author":"Luo","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.leukres.2015.07.008_bib0235","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF03256368","article-title":"Programmed cell death 4 (PDCD4) enhances the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by inhibiting the PI3K\/Akt signaling pathway","volume":"14","author":"Wang","year":"2010","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.leukres.2015.07.008_bib0240","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1074\/jbc.M707224200","article-title":"Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells","volume":"283","author":"Frankel","year":"2008","journal-title":"J. Biol. Chem."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615303519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615303519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T10:16:29Z","timestamp":1599300989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212615303519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0145212615303519"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2015.07.008","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silencing of miR-21 sensitizes CML CD34+ stem\/progenitor cells to imatinib-induced apoptosis by blocking PI3K\/AKT pathway","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2015.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}